Navigation Links
WriteResult Selected for Irritable Bowel Syndrome Studies
Date:3/26/2013

Cranford, NJ (PRWEB) March 26, 2013

WriteResult, leading provider of clinical data management solutions, announced that they have been selected as the ePRO vendor for two clinical studies evaluating the efficacy and safety of a new drug in patients with Irritable Bowel Syndrome (IBS).

According to the International Foundation for Functional Gastrointestinal Disorders (IFFGD), IBS affects between 25 and 45 million people in the United States. About 2 in 3 IBS sufferers are female, while about 1 in 3 IBS sufferers are male [1]. Although the exact cause of IBS is unknown, new drugs are being tested to treat the symptoms of IBS which include stool urgency and pain or discomfort in the abdomen.

In addition to Gastroenterology and disease-specific PRO instruments such as the IBS-QoL and IBS-SS, WriteResult’s digital pen solution has been utilized to collect Patient Reported Outcomes (PROs) in other treatment areas including Dermatology, Rheumatology, Infectious Disease, Pain and Inflammatory Disease. The company has extensive experience with over 15 different health assessment questionnaires, such as HAQ-DI, DLQI, EQ-5D™ and SF-36®, in Phase II and Phase III studies worldwide.

About WriteResult
WriteResult offers full-service data management solutions for clinical research through the collection and verification of ePROs leveraging digital pen and paper technology. Since 2006 WriteResult has partnered with study sponsors to deliver a simple and effective ePRO solution — rapid study startup with clean, real-time data using a technology that’s intuitive for sites and patients.

For more information about WriteResult, please email solutions(at)writeresult(dot)com or call (908) 272-4787.

References
[1] International Foundation for Functional Gastrointestinal Disorders, http://www.aboutibs.org/, Last accessed March 2013

Read the full story at http://www.prweb.com/releases/2013/3/prweb10562151.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. WriteResult Releases White Paper on Utilizing Digital Pen for ePRO
2. Cleveland Clinic selected to participate in National MDS Clinical Research Consortium
3. IQware Solutions is Pleased to Announce that IQware MTM has Been Selected by the Tennessee Pharmacists Research and Education Foundation (TPREF)
4. ONR system selected to help DoD track human subjects studies
5. Hospital of the University of Pennsylvania selected to lead US nurse-training initiative
6. Half-match bone marrow transplants wipe out sickle cell disease in selected patients
7. Wolters Kluwer Health selected as publisher for the Harvard Review of Psychiatry
8. Dr. Joan Miller selected to deliver the prestigious Edward Jackson Memorial Lecture
9. Mangos Selected by Liberty Sport as Advertising Agency Partner
10. Bioforce USA Announces Herbatint Herbal Hair Color Selected For Tips and Trends Again
11. Chicago Hat Designer Tonya Gross Selected by Online Retailer Zappos.com for 2013 Emerging Designer Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... (PRWEB) , ... April 26, ... ... which provides an agile ecosystem and domain expertise for sponsors and CROs ... randomization and trial supply management (RTSM) software platform. Bioclinica AGILE RTSM ...
(Date:4/25/2017)... ... April 25, 2017 , ... Coalition ... for Duchenne muscular dystrophy, and funding for Duchenne research, congratulates Capricor Therapeutics ... HOPE clinical trial in Duchenne announced today. , Coalition Duchenne funded studies ...
(Date:4/25/2017)... ... April 25, 2017 , ... Lake Park Dental is now accepting new ... in Lutz, FL. With the help of this highly-effective, yet convenient system, patients ... complications, more discretion and less pain. , Drs. Sarah Jockin, Nicole Morganti, Sara ...
(Date:4/25/2017)... ... 2017 , ... Buyers and sellers in the thriving multi-billion dollar cannabis marketplace ... help but be heartened by the industry’s current surge. But another thing that unifies ... smell.” At last they can simply, safely and effectively end their aroma anguish ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... products, is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s ... health in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... , April 24, 2017 Solentim, ... today announced the addition of a major new ... In-situ Plate Seeding,). The VIPS has been developed ... 384 well microplates as part of the process ... offers a simple and more reliable solution when ...
(Date:4/20/2017)... PLANO, Texas , April 20, 2017  Vivify ... via mobile devices, has been awarded a very significant ... care via EMRs to continual care via digital health. ... of key intellectual property and further secures Vivify,s position ... Vivify, launched in 2009, was the first company to ...
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Company,s consumer product development program, based on ... Society for Investigative Dermatology (SID) 76 th ... and promote the sciences relevant to skin health ...
Breaking Medicine Technology: